Landing angel investment involves a little bit more than calling up a bunch of rich guys and hoping for the best.Obtaining that initial investment is often a huge hurdle for startups, but once the cash comes in, it provides a critical source of early funding — lifeblood for young, hungry companies. And as the traditional [...]

Fresh off an $18 million fundraise, biomarker testing company Cleveland HeartLab plans today to sign a lease for 27,000 square feet of new office space.HeartLab CEO Jake Orville told MedCity News in July about the company’s intention to lease new space in Cleveland’s growing Health-Tech Corridor between downtown and University Circle. Now, those plans will [...]

Biomarker test-maker Cleveland HeartLab has closed an $18.4 million series B round of funding, which was led by two Boston-area investors.The size of the round is a testament to the explosive growth that the young company has achieved in less than two years of existence after being spun out from Cleveland Clinic — and the [...]

Cleveland HeartLab, which makes a biomarker-based heart test, has rebuffed an acquisition offer and instead taken an Ohio tax credit to keep growing the company, according to Ohio government officials.The company received a six-year tax credit from the state of Ohio that’s valued at nearly $423,000. State officials claimed that without the tax credit, [...]

Cleveland is already well-known for its high quality medical care. But its reputation is growing elsewhere.Some of the nation’s best and brightest are flocking to University Circle to be on the cutting edge of the biotech innovation. Channel 3′s Maureen Kyle continues our “Brain Gain” series with a look at how this could [...]

In the words of Cleveland HeartLab CEO Jake Orville, business has “exploded” since the beginning of the year, just months after his company launched a proprietary test for cardiac inflammation under a fee-for-service model. Cleveland HeartLab is a CLIA-certified and CAP-accredited reference lab that does an array of lipid and inflammation tests for clients, including CardioMPO, a proprietary test for cardiac inflammation marker myeloperoxidase.

Tommy G. Thompson, former secretary of the U.S. Department of Health and Human Services-turned-healthcare consultant, will headline Cleveland HeartLab‘s first annual symposium on cardiovascular disease.The symposium Where Inflammation Meets Lipids (pdf) has attracted more than a dozen thought-leaders who will speak on a range of cardiovascular disease prevention, diagnosis and management topics. The symposium [...]

Cleveland HeartLab LLC has added a test of low-density lipoprotein, the so-called “bad cholesterol,” to its portfolio of heart-inflammation tests.The company’s NMR LipoProfile test measures and counts LDL particles, which carry cholesterol in the blood and can build up on artery walls, leading to atherosclerosis and cardiovascular disease.The [...]

Updated 4:29 p.m., March 18, 2010The cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology, thought Jake Orville, president and chief executive of Cleveland HeartLab.The question: How to take a test for the biomarker to market?var page_count = “off”; [...]

Updated 4:24 p.m.Cleveland Clinic spinoff Cleveland HeartLab has completed a $3 million fundraising round, and named its executives and advisers.Investors in the round included Glengary LLC, Second Generation Ltd. and Zapis Capital Group LLC, all in Northeast Ohio, according to a company release.Cleveland HeartLab is a clinical reference laboratory specializing in next-generation cardiovascular disease prevention, [...]